{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:41:29Z","timestamp":1760298089752},"reference-count":31,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2009,6,2]],"date-time":"2009-06-02T00:00:00Z","timestamp":1243900800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[2009,11,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>High\u2010risk human papillomavirus (H\u2010HPV) infection is strongly linked to cervical neoplasia, but its role in detecting glandular lesions (GLs) is unclear. In the cervix, carbonic anhydrase IX (CA\u2010IX) is expressed in cervical neoplasia, but rarely in the benign cervix. The diagnostic utility of these biomarkers was evaluated in women with a cytologic diagnosis of atypical glandular cells (AGC). H\u2010HPV was detected using hybrid capture 2 (HC2) in liquid\u2010based cytology, and CA\u2010IX immunoreactivity was studied on conventional Pap smears. Of 403 patients, 111 (28%) were positive for significant cervical lesions (SCLs) including CIN2, CIN3, adenocarcinoma <jats:italic>in situ<\/jats:italic> or invasive carcinoma. CA\u2010IX testing alone (<jats:italic>n<\/jats:italic> = 403) had a sensitivity of 75, 95 or 65% for SCLs, significant GLs or squamous lesions (SLs), respectively, with a specificity of 88% and a false negative rate (FNR defined as 1 minus negative predictive value) of 10%. Testing for H\u2010HPV (<jats:italic>n<\/jats:italic> = 122) had a sensitivity of 97, 100 or 96% for SCLs, GLs or SLs, respectively, with a specificity of 87% and a FNR of 1%. The combination of CA\u2010IX and H\u2010HPV testing (<jats:italic>n<\/jats:italic> = 122), collectively, had the same sensitivity, specificity and FNR for SCLs, GLs or SLs as H\u2010HPV testing alone. The conclusions of our study are that both H\u2010HPV and CA\u2010IX testing are useful diagnostic markers for GLs. However, H\u2010HPV testing is a better diagnostic marker for SLs. The combination of CA\u2010IX with H\u2010HPV testing does not improve the diagnostic accuracy for cervical neoplasia in women with AGC diagnosis over that of H\u2010HPV testing alone. \u00a9 2009 UICC<\/jats:p>","DOI":"10.1002\/ijc.24615","type":"journal-article","created":{"date-parts":[[2009,6,2]],"date-time":"2009-06-02T15:29:00Z","timestamp":1243956540000},"page":"2434-2440","source":"Crossref","is-referenced-by-count":19,"title":["Carbonic anhydrase IX and human papillomavirus as diagnostic biomarkers of cervical dysplasia\/neoplasia in women with a cytologic diagnosis of atypical glandular cells: A Gynecologic Oncology Group study in United States"],"prefix":"10.1002","volume":"125","author":[{"given":"Shu\u2010Yuan","family":"Liao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William H.","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Kauderer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas A.","family":"Bonfiglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan L.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen M.","family":"Darcy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randy","family":"Carter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuji","family":"Hatae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyuba","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick M.","family":"Spirtos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric J.","family":"Stanbridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,9,18]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/CA.2007.0010"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2000.5826"},{"key":"e_1_2_6_4_2","first-page":"115","article-title":"The Bethesda System for reporting cervical\/vaginal cytologic diagnosis: revised after the second National Cancer Institute Workshop, April 29\u201330, 1991","volume":"37","author":"Anonymous","year":"1993","journal-title":"Acta Cytol"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.16.2114"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1309\/HL0B-C7Y6-AC77-ND2U"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1108::AID-CNCR23>3.0.CO;2-D"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1996.0270"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(98)70368-0"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/dc.10316"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(89)90001-2"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10312"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(99)90143-0"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910540218"},{"key":"e_1_2_6_15_2","first-page":"2877","article-title":"Cloning and characterization of MN, a human tumor\u2010associated protein with a domain homologous to carbonic anhydrase and a putative helix\u2010loop\u2010helix DNA binding segment","volume":"9","author":"Pastorek J","year":"1994","journal-title":"Oncogene"},{"key":"e_1_2_6_16_2","first-page":"598","article-title":"Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinoma","volume":"145","author":"Liao SY","year":"1994","journal-title":"Am J Pathol"},{"key":"e_1_2_6_17_2","first-page":"2827","article-title":"Identification of the MN\/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney","volume":"57","author":"Liao SY","year":"1997","journal-title":"Cancer Res"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64038-2"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.16.3660"},{"key":"e_1_2_6_20_2","first-page":"6394","article-title":"Carbonic anhydrase(CA\u2010IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix","volume":"61","author":"Loncaster JA","year":"2001","journal-title":"Cancer Res"},{"key":"e_1_2_6_21_2","first-page":"549","article-title":"Expression of the MN antigen in cervical Papanicolaou smears is an early diagnostic biomarker of cervical dysplasia","volume":"5","author":"Liao SY","year":"1996","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.05.064"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64619-6"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.16.2120"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1309\/N7KCUP0VD59GDJEL"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2005.03.044"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/dc.20369"},{"key":"e_1_2_6_28_2","volume-title":"The Bethesda system: terminology for reporting cervical\/vaginal cytologic diagnoses: definitions, criteria and explanatory notes for terminology and specimen adequacy","author":"Kurman RJ","year":"1994"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-07-2904"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01305-06"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.1455"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1438.2006.00460.x"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.24615","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.24615","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T22:52:07Z","timestamp":1695941527000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.24615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,18]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,11,15]]}},"alternative-id":["10.1002\/ijc.24615"],"URL":"https:\/\/doi.org\/10.1002\/ijc.24615","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,18]]}}}